JP2003505518A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003505518A5 JP2003505518A5 JP2001513438A JP2001513438A JP2003505518A5 JP 2003505518 A5 JP2003505518 A5 JP 2003505518A5 JP 2001513438 A JP2001513438 A JP 2001513438A JP 2001513438 A JP2001513438 A JP 2001513438A JP 2003505518 A5 JP2003505518 A5 JP 2003505518A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmacological agent
- pharmacological
- ligand
- secr
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002831 pharmacologic agent Substances 0.000 description 53
- 238000000034 method Methods 0.000 description 47
- 108010005584 serpin-enzyme complex receptor Proteins 0.000 description 41
- 239000003446 ligand Substances 0.000 description 38
- 102000039446 nucleic acids Human genes 0.000 description 23
- 108020004707 nucleic acids Proteins 0.000 description 23
- 150000007523 nucleic acids Chemical class 0.000 description 23
- 230000000144 pharmacologic effect Effects 0.000 description 22
- 239000000203 mixture Substances 0.000 description 19
- 210000000981 epithelium Anatomy 0.000 description 18
- 210000004556 brain Anatomy 0.000 description 17
- 238000002347 injection Methods 0.000 description 16
- 239000007924 injection Substances 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 16
- 241000124008 Mammalia Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 241000700605 Viruses Species 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 208000018737 Parkinson disease Diseases 0.000 description 3
- 210000005013 brain tissue Anatomy 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 102000015728 Mucins Human genes 0.000 description 2
- 108010063954 Mucins Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 2
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 2
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000003087 receptor blocking agent Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- OBKXEAXTFZPCHS-UHFFFAOYSA-M 4-phenylbutyrate Chemical group [O-]C(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-M 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010006417 Bronchial carcinoma Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004559 Interleukin-13 Receptors Human genes 0.000 description 1
- 108010017511 Interleukin-13 Receptors Proteins 0.000 description 1
- 102000010787 Interleukin-4 Receptors Human genes 0.000 description 1
- 108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 208000005119 Necrotizing Pneumonia Diseases 0.000 description 1
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 102000008847 Serpin Human genes 0.000 description 1
- 108050000761 Serpin Proteins 0.000 description 1
- 208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
- 239000000430 cytokine receptor antagonist Substances 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N gamma-phenylbutyric acid Natural products OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005171 mammalian brain Anatomy 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14597099P | 1999-07-29 | 1999-07-29 | |
| US60/145,970 | 1999-07-29 | ||
| PCT/US2000/020545 WO2001008708A2 (en) | 1999-07-29 | 2000-07-28 | Enhanced delivery via serpin enzyme complex receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003505518A JP2003505518A (ja) | 2003-02-12 |
| JP2003505518A5 true JP2003505518A5 (https=) | 2007-08-30 |
Family
ID=22515370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001513438A Withdrawn JP2003505518A (ja) | 1999-07-29 | 2000-07-28 | セルピン酵素複合体受容体を介する増強された送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20040152653A1 (https=) |
| EP (1) | EP1200616A2 (https=) |
| JP (1) | JP2003505518A (https=) |
| AU (1) | AU782051B2 (https=) |
| CA (1) | CA2391348A1 (https=) |
| WO (1) | WO2001008708A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2390652C (en) | 1999-11-08 | 2011-03-29 | Ipf Pharmaceuticals Gmbh | Human circulating virus-inhibiting peptide (virip) and its use |
| EP1351704B1 (en) | 2000-12-21 | 2007-03-07 | Nektar Therapeutics | Storage stable powder compositions of interleukin-4 receptor |
| GB0106315D0 (en) | 2001-03-14 | 2001-05-02 | Ich Productions Ltd | Transfection complexes |
| US7655629B2 (en) | 2002-12-19 | 2010-02-02 | Ipf Pharmaceuticals Gmbh | Peptides and their use for the treatment of HIV infections |
| WO2009087474A2 (en) | 2008-01-08 | 2009-07-16 | Akthelia Pharmaceuticals | Agonists for antimicrobial peptide systems |
| AU2010306940A1 (en) | 2009-10-12 | 2012-06-07 | Smith, Larry | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| JP5687354B2 (ja) * | 2010-11-26 | 2015-03-18 | ユニバーシティ・オブ・ザ・ウィットウォータースランド・ヨハネスブルグＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｔｈｅ Ｗｉｔｗａｔｅｒｓｒａｎｄ， Ｊｏｈａｎｎｅｓｂｕｒｇ | 薬物送達デバイス |
| JP2015111050A (ja) * | 2012-03-28 | 2015-06-18 | 国立大学法人九州大学 | Ｋａｌｌｉｓｔａｔｉｎ蛋白質による脳梗塞検査方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0114777B1 (fr) * | 1983-01-21 | 1990-08-01 | Transgene S.A. | Nouveaux vecteurs d'expression et leur application à la préparation d'une protéine ayant l'activité de l'antitrypsine-alpha 1 humaine |
| US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| JPH06509327A (ja) * | 1991-04-18 | 1994-10-20 | ザ ユー エー ビー リサーチ ファンデーション | エラスターゼ抑制のための組成とその方法 |
| FR2711523B1 (fr) * | 1993-10-26 | 1996-02-16 | Transgene Sa | Procédé de préparation d'un aérosol viral. |
| US5972901A (en) * | 1994-03-23 | 1999-10-26 | Case Western Reserve University | Serpin enzyme complex receptor--mediated gene transfer |
| WO1997024453A1 (en) * | 1995-12-28 | 1997-07-10 | Chiron Corporation | Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| US6287857B1 (en) * | 1998-02-09 | 2001-09-11 | Genzyme Corporation | Nucleic acid delivery vehicles |
-
2000
- 2000-07-28 CA CA002391348A patent/CA2391348A1/en not_active Abandoned
- 2000-07-28 AU AU62397/00A patent/AU782051B2/en not_active Ceased
- 2000-07-28 JP JP2001513438A patent/JP2003505518A/ja not_active Withdrawn
- 2000-07-28 EP EP00948981A patent/EP1200616A2/en not_active Withdrawn
- 2000-07-28 WO PCT/US2000/020545 patent/WO2001008708A2/en not_active Ceased
-
2003
- 2003-11-07 US US10/703,206 patent/US20040152653A1/en not_active Abandoned
-
2006
- 2006-06-20 US US11/455,791 patent/US20060228407A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100291620B1 (ko) | 부갑상선호르몬의활성단편의폐를통한전달방법 | |
| JP4883840B2 (ja) | プロトン化／酸性化核酸の肺輸送 | |
| Kaplan et al. | Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential | |
| JP2009518025A5 (https=) | ||
| JP2005511644A (ja) | 核酸およびカチオン性アミノグリコシドの組成物ならびにそれを使用および調製する方法 | |
| JP2023126658A5 (https=) | ||
| JP2003505518A5 (https=) | ||
| JP2021526505A5 (https=) | ||
| JP2022529262A5 (https=) | ||
| JP4537956B2 (ja) | 喘息治療剤 | |
| CN114533706B (zh) | 一种用于防治呼吸道疾病的雾化吸入制剂及其应用 | |
| JP2002541217A (ja) | 細胞内感染の処置 | |
| JP2013537168A (ja) | 慢性肺疾患の処置のためのトレフォイル因子（ｔｆｆ） | |
| JP2002541125A (ja) | エアロゾル送達のためのポリエチレンイミン：ｄｎａ製剤 | |
| US20060228407A1 (en) | Enhanced delivery via serpin enzyme complex receptor | |
| KR20250051534A (ko) | Fc 절편이 융합된 안지오텐신 전환효소 2를 포함하는 나노디스크 및 이의 용도 | |
| KR20040097249A (ko) | 중공 나노입자를 형성하는 단백질에 질환 치료용 세포도입 물질을 융합시킨 약제 | |
| WO2014012559A1 (en) | Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma | |
| Brown et al. | Propellant-driven aerosols of DNA plasmids for gene expression in the respiratory tract | |
| AU2005201180B2 (en) | Enhanced delivery via serpin enzyme complex receptor | |
| CN113527509B (zh) | 含有重组蛋白和保护蛋白的复合物在治疗肺鳞癌中的应用 | |
| IL275328B1 (en) | Methods for inducing immune tolerance and reducing antibody response against drugs | |
| KR20080074085A (ko) | 기도에 영향을 미치는 염증 질환에 있어서 조직 인자 경로억제제의 기도 투여법 | |
| Andrade et al. | Pulmonary delivery of biopharmaceuticals | |
| WO2026067851A1 (zh) | 一种关联杆状病毒凋亡抑制蛋白5的组合物及其制备方法和应用 |